Relmada Therapeutics @relmada
Relmada Therapeutics (Nasdaq: $RLMD) is a clinical-stage biotechnology company developing novel therapies for CNS diseases and bladder cancer. relmada.com Coral Gables, FL Joined February 2014-
Tweets816
-
Followers620
-
Following966
-
Likes91
June marked continued progress across Relmada’s oncology and CNS pipeline programs. We remain focused on advancing innovative therapies for patients with signifi cant unmet medical needs. bit.ly/4oJGB4U #Biotech #Oncology #CNS $RLMD
Relmada Therapeutics has joined the Russell 2000® and Russell 3000® Indexes, marking a meaningful accomplishment for the company as we continue advancing ongoing progress, including robust data for NDV-01 in NMIBC. Learn more: bit.ly/3T98AAA $RLMD @FTSERussell
Relmada continues advancing its pipeline with upcoming development milestones expected in 2026. Stay updated: bit.ly/4xlSALq $RLMD
Beyond oncology, Relmada is advancing sepranolone, a novel candidate being evaluated for compulsive behaviors through modulation of GABAₐ receptor activity. Learn more about our CNS pipeline: bit.ly/4opJLwc $RLMD
Focused on innovation. Driven by patients. Relmada Therapeutics is committed to advancing therapies for oncology and CNS disorders with signifi cant unmet need. bit.ly/4oJGB4U #Biotech #HealthcareInnovation $RLMD
NDV-01 is administered as a ready-to-use sustained-release Gem/Doce formulation administered in under 5 minutes. Learn more about the program: bit.ly/4vKedDI $RLMD
Did you know non-muscle invasive bladder cancer (NMIBC) represents approximately 75–80% of newly diagnosed bladder cancer cases? Relmada is focused on advancing therapies designed to address ongoing treatment challenges in NMIBC. Learn more: bit.ly/4vKedDI $RLMD
We're pleased to welcome Michael Quirk, PhD, as Senior Advisor for Relmada's Sepranolone Program. His CNS expertise will help advance sepranolone, Relmada’s GABAA receptor modulator for Prader-Willi syndrome and CNS disorders. Read more: bit.ly/3SAHIt1 $RLMD
Advancing innovation in NMIBC. NDV-01 is designed to support prolonged bladder exposure and streamlined in-offi ce administration for patients with non-muscle invasive bladder cancer. Learn more about our pipeline: bit.ly/4opJLwc $RLMD
NDV-01 is designed to support sustained drug exposure within the bladder through a novel formulation approach. Learn more: bit.ly/4oJGB4U $RLMD
Clinical development is guided by data, consistency, and a focus on advancing meaningful treatment options. Learn more: bit.ly/4oJGB4U $RLMD
Relmada Therapeutics will participate in the @Jefferies Global Healthcare Conference, June 2-4, 2026 in New York. CEO Sergio Traversa and CFO Maged Shenouda will speak in a fireside chat on June 4, 2026 at 12:50 PM ET. Details: bit.ly/4v9XtFq $RLMD #JefferiesHealthcare
Sustained local drug exposure continues to be a key focus in advancing therapies for non-muscle invasive bladder cancer. Innovative approaches designed to maintain therapeutic presence in the bladder may help address persistent treatment challenges. bit.ly/4oJGB4U $RLMD
Efficient administration remains an important consideration in oncology care, notably in settings where repeated treatments may be required. NDV-01 is designed with a streamlined delivery process that may support ease of use in clinical practice. bit.ly/4oJGB4U $RLMD
Bladder cancer presents unique challenges in how therapies are delivered and retained within the bladder environment. Learn more: bit.ly/4oJGB4U $RLMD
Advancing therapies in oncology requires precision across formulation, delivery, and clinical development. Learn more: bit.ly/4oJGB4U $RLMD
Today at #AUA26: Relmada presents an oral Trial-in-Progress session for REL-NDV01-301, the Phase 3 NDV-01 study in intermediate-risk NMIBC. 📍 Hall B/The Square/Learning Lab 🕘 9:56–10:04 AM ET Read more: bit.ly/4dlT10d $RLMD
Today at #AUA26: Relmada presents NDV-01 Phase 2 poster IP02-03 in high-risk NMIBC. 📍 Room 146A, Walter E. Washington Convention Center 🕖 7:00–9:00 AM ET Details: bit.ly/4dlT10d $RLMD
Reminder: NDV-01 will be featured this week at #AUA26 as Relmada advances the program across multiple NMIBC settings, including its Phase 3 registrational study expected to begin mid-2026. 📌 May 15, 7–9 AM ET 📌 May 17, 9:56–10:04 AM ET Details: bit.ly/4dlT10d $RLMD
Relmada Therapeutics reports first quarter 2026 financial results and provides business update. Read more: bit.ly/4d89pRW $RLMD
Hailey Osorio @haileyosorio18
3 Followers 274 Following 🤍 Hailey · 📸 · Aries energy · golden hour mood · sunny side
Martin 🏹 @MoonShotMarty
193 Followers 123 Following 🌐 Secular Investor, investing where policy has no alternative: $KRKNF at €1,55 $ALM at €0,62 $RLMD at €0,22 🇦🇹 Austrian School of Economics 🏛 Stoic
morten @M0RTEN_SH
1 Followers 34 Following
PRISM MarketView @PrismMarketView
5K Followers 3K Following The PRISM stock indexes track small/micro-cap companies across a diverse spectrum of industries including clean energy, biotech and next-gen tech.
anwar alfoudari @AnwarAlfoudari
10 Followers 123 Following
Luke | Garden Cleanup... @lukaszxlx02
359 Followers 543 Following 🌲🏡🌱🪴🧑🌾🌳🌸🌿 Solo Game Developer. Try DEMO and Wishlist 👇👇 https://t.co/nOFvbUQJE3
MOHD DANISH @MOHDDANISH2012
0 Followers 60 Following
Inflection Point Capi... @Dark_Stormy23
21 Followers 4K Following First, you learn, then you earn, and then you turn your edge into a machine. To dine with classes serve the masses. Gunners at ❤️
tony @Anthony_TayIor
239 Followers 326 Following hell is immeasurably deep. paywalls are for losers 🏴☠️
Karan Naik @karannaik_
231 Followers 374 Following
Phillip Wiggins @WigginsPhi6573
6 Followers 13 Following
Atanas G. Atanasov @_atanas_
128K Followers 112K Following Lead Editor: #CRBIOTECH & #ExplorDHT | Chair of Pharmacology at DPU | Prof of IGAB-PAS | Leader: #DHPSP & #INPST | Author of #HealthHacksThatWork
Modern Monetary Bio M... @MonetaryBioMan
548 Followers 744 Following Bio Buyside Analyst | Stocks | Options | CFA | Opinion/speculation only & not advice/solicitation | May be L/S names, do your own diligence, consider conflicts
SMin @SMMNY4
0 Followers 6 Following
Robin Williams @RobinWill2019
0 Followers 59 Following
Kyle Boulanger @KyleBoulanger22
450 Followers 882 Following
Enemy of the Leviatha... @kirk_quotes
151 Followers 1K Following "The bureaucracy is a self-perpetuating organism that grows by creating problems it can then claim to be needed to solve." Thomas Sowell
Avi Levy @AviLevy
37 Followers 153 Following
Andrew Hill @AndrewH44926751
1 Followers 15 Following
Abivax_shareholder_Ss... @Biotech_8899
65 Followers 84 Following
Mona Rch @TirayeurHegerie
29 Followers 775 Following
LenaMiddleton @TA1lW39A7ZxYPD0
1 Followers 266 Following
AdvisorShares @AdvisorShares
10K Followers 156 Following Advisor to Active ETFs - Tweets, Retweets, Likes are not a recommendation, advice or a solicitation of any security. For ETF info: https://t.co/WlU57F1QOq #MSOGang
Bob @Bob09290029293
0 Followers 1K Following
Crypto$ Doode @LUXBANX
945 Followers 2K Following There’s always another play🐐Trenches 🪖momentum 🐊 DD AND CHARTS GET THE BAG🐊Crypto$ Doode Not a investment advisor 🐊Pacpennys🐊
Chris @chitown085
230 Followers 252 Following
Ana @itsadgy
2 Followers 41 Following
Kastriot @kastriooot8
1K Followers 220 Following I’ve been monitoring my stocks for at least one or two years before I write about them. And I monitor them EVERY single day. NFA. #bullisheveryday 🎱
Aziz Gharbi @ReadyForHijrah
8 Followers 62 Following
AmericanLibertyX @RyanJam57150440
454 Followers 2K Following 🇺🇸 American | Free Iran | Protect ✝️ | Defend 🇮🇱 | Devoted Father of 4 & Husband | Conservative | Trust In Trump | 2A = Human Rights
SDPur @SDPur1
22 Followers 241 Following
DCF_ValueLab🇺🇸 @Orquoocou21221
37 Followers 2K Following 15-30% Monthly | 2 High-Conviction Stocks.Short-Term Gains: 15-20% in Days/Weeks.DM "JOIN" for WhatsApp Alerts. Live Trade Signals • Market Analysis
[email protected] @avarallire68683
1 Followers 3 Following
Kasia Brakoniecka Pot... @Kpotaca
0 Followers 138 Following
Shaya Feedman שיי�... @ShayaFeedman
3K Followers 1K Following Co-Founder @ Deep Specter Former Head of InfoSec @ Porsche Digital I make money on mispricing. Value investor | Put writer | Short seller
Sasarn @Sasarn961
20 Followers 1K Following
Mackenzie P @mpadvisorshares
999 Followers 655 Following
Brad Loncar @bradloncar
82K Followers 367 Following #Biotech, Founder of @BiotechTV, KC native, @univmiami hurricane.🧬🙌
[email protected] @avarallire68683
1 Followers 3 Following
The Green Blueprint @_GreenBlueprint
2K Followers 470 Following A show about the architects of the clean energy economy. Hosted by Lara Pierpoint. Produced by @_LatitudeMedia. Follow wherever you get your podcasts.
Contemporary OB/GYN® @ContempOBGYN
17K Followers 5K Following Contemporary OB/GYN® is a peer-reviewed journal providing practical information for doctors by doctors.
U.S. Surgeon General @Surgeon_General
1.2M Followers 166 Following Official X account for the U.S. Surgeon General. Tweets before 01/20/25 are from prior federal officials. Privacy: https://t.co/SrVlrTW1gb
Yeji Jesse Lee | 이�... @jesse_yeji
2K Followers 1K Following senior reporter covering the business of healthcare @law360, formerly @businessinsider & @globeandmail | reach out at [email protected]
Neuroscience News @NeuroscienceNew
506K Followers 5K Following Official Neuroscience News Twitter. Brain research news articles on neuroscience, psychology, AI, neurology, brain cancer, robotics, mental health & science.
womenshealth.gov @womenshealth
764K Followers 753 Following Official X account for the U.S. Dept. of Health and Human Services Office on Women’s Health. Following/being followed and RTs do not equal endorsement.
CDC_eHealth @CDC_eHealth
611K Followers 143 Following This profile is no longer active as of April 2023. For regular updates from CDC, follow @CDCgov on Twitter or visit https://t.co/UT9pRQBS9G.
Gully Foyle @bluejaunt100
805 Followers 507 Following RTFM for drug development and the regs. No positions, just comments prn.
MIKE GUILTINAN @BIOBETTER
383 Followers 30 Following
Clark H @Clarksterh
2K Followers 559 Following Eclectic Interests: Roots of culture and cultural change, biotech, space, pedagogy. Opening Overton Windows (first and foremost), including my own
Journals of The Ameri... @APAPubJournals
12K Followers 139 Following Official account for the journals of @APA_Publishing.
Chris Carper @mtheory11bio
5K Followers 354 Following Mostly talk about biotech. Tweets are not meant to be recommendations
Healthline @Healthline
67K Followers 679 Following We’re committed to being your trusted ally in your pursuit of health and well-being. Count on us for information, guidance, inspiration, and genuine caring. 🌱
Kelly Greenwood @KellyAGreenwood
608 Followers 522 Following Founder, Board Member, & former CEO @MindShareOrg, changing the culture of workplace #mentalhealth | @HarvardBiz & @Forbes Contributor | @KelloggSchool, @DukeU
Mind Share Partners I... @MindShareOrg
841 Followers 829 Following We're changing the culture of workplace #mentalhealth so both employees & organizations can thrive. Get our free manager checklist using the link below⬇
Linxens @Linxens
2K Followers 2K Following Linxens gives users the best connection possible with its expertise in Healthcare, IOT, eGovernment, access control. Linxens, opening the way to a better life.
cyprotex @cyprotex
730 Followers 53 Following We are the world leader in predictive toxicology and ADME research with several proprietary technologies and laboratories in the UK and US.
Evotec @Evotec
4K Followers 134 Following A drug discovery & development solutions company with a global presence.
DelveInsight @delve_insight
290 Followers 2K Following #DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry
Mehabe @mehabecapital
2K Followers 67 Following We help you scale your business. Get in touch. [email protected] Site: https://t.co/Oj81TZFNmE Telegram: https://t.co/oRmiBIRCCf
GenBio Inc @GenBioUSA
1K Followers 2K Following GenBio Inc is a pre-clinical USA based #biotech with a #dosage & #toxicology #IND program. #biotechnology https://t.co/sc0Sr4l8By https://t.co/MnQnfXGJ0K
Maya Kaufman @mayakauf
14K Followers 3K Following Covering politics, policy and power in health care for @POLITICO New York. Send tips to [email protected] or mayakaufman.11 on Signal 🕵🏻
Dr Boris Nikolov @boris_nikolov7
1K Followers 3K Following A father, husband, clinical research physician, CEO of IMIC Research
GameToyBrickMan @GameToyBrickMan
1K Followers 1K Following I didn't choose the Lego Life, the Lego Life chose me.
SmallCapsDaily @SmallCapsDaily
1K Followers 70 Following Smallcaps News and Smallcaps Research. We cover all things Smallcaps.
Rona Rebound @ronarebound
522 Followers 1K Following What will your investment today grow to if stocks rebound to pre-pandemic prices? 📈
The College on Proble... @CPDDorg
2K Followers 526 Following CPDD is the longest standing professional association in the United States addressing problems of drug dependence and abuse. #cpdd26 Portland, OR
Psych Congress Networ... @PsychCongress
3K Followers 1K Following The number-one source for cutting-edge content and education in the mental health care and addiction treatment fields.
David Janezic @djanezic9
1K Followers 5K Following Associate Head Men's Soccer Coach, St. John’s University, Member of the Big East Conference, Father of Four, Husband
Oppenheimer & Co. Inc... @Oppenheimer
5K Followers 97 Following Oppenheimer is a leading global full-service brokerage and investment bank.
Christina Oehler @ChristinaOehler
106 Followers 299 Following
Seeking Alpha @SeekingAlpha
332K Followers 231 Following A global leader in crowdsourced U.S. investment research, powered by one of the largest and most vibrant investor communities.
CINP @theCINP
1K Followers 3K Following CINP (The International College of Neuropsychopharmacology) is the oldest global neuropsychopharmacology organisation. #CINP2026 | June 26-29, 2026 in Glasgow
Drug Discovery World @DDWJournal
3K Followers 2K Following The Global Business Review of Drug Discovery and Development
Akhila Reddy M.D. @Reddysuppcare
2K Followers 841 Following Professor & Section Chief #Palliative & #SupportiveCare @MDAndersonNews #pallonc #hpm #hapc; #AutismMom; own tweets; USTA 4.0 tennis league player; STH @Astros
Will Debarros @will_debarros
536 Followers 3K Following Love of all things #biotech, #technology, #sports, and #humanity
Pharma Journalist @pharmjournalist
357 Followers 504 Following Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical.
Jasmine Harris @JasmineFSG
77 Followers 301 Following Editor of @MedChemNet, tweeting about #medicinalchemistry and #drugdiscovery. @UniofNottingham @NottsChemistry graduate. Views expressed are my own.
MHA Policy Team @MHAPolicy
6K Followers 841 Following This account is no longer active. Please follow @MentalHealthAm for updates.
Mary Giliberti @MaryTGiliberti
2K Followers 377 Following mental health advocate and mom of three; Chief Public Policy Officer, Mental Health America.
AMA @AmerMedicalAssn
695K Followers 6K Following American Medical Association - Physicians' powerful ally in patient care. RT does not equal endorsement. #FightingForDocs | AMA president: @PresAmerMed
flylemurs @flylemurs
38 Followers 31 Following
intratio @intratio
2K Followers 1 Following We have built the state-of-the-art portfolio optimization algorithm that makes use of our proprietary stock price prediction algorithm.
Offres de Stage @un_stage
10K Followers 9K Following Diffusion d'annonces de stage dans le digital #Emploi #RH #Recrutement #Web Mentionner @Un_stage pour diffuser votre annonce #i4emploi #RH #Ecole #Formation
Arthur C Evans, Ph.D @ArthurCEvans
10K Followers 9K Following @APA CEO. Psychologist, Speaker, Tweeting on Health Policy, Innovation, Transformational leadership. Former commissioner of #Philadelphia @dbhids
Kim Painter @KimPainter
12K Followers 818 Following I'm a veteran USA Today health reporter, now freelancing for other outlets.
ed silverman @edsilverman
5K Followers 140 Following Pharmalot columnist and senior writer at @STATnews.. former WSJer.. proud dad; likes music, dogs and taking napsTrends for United States
You might like
